# Peri-Incisional Drug Injection in Lumbar Spine Surgery

> **NCT03513445** · PHASE3 · WITHDRAWN · sponsor: **University of Minnesota**

## Conditions studied

- Lumbar Disc Herniation
- Degenerative Disc Disease
- Spondylolisthesis

## Interventions

- **DRUG:** Morphine
- **DRUG:** Epinephrine
- **DRUG:** naropin

## Key facts

- **NCT ID:** NCT03513445
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-06-01
- **Primary completion:** 2022-03
- **Final completion:** 2022-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No participants enrolled
- **Last updated:** 2022-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03513445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03513445, "Peri-Incisional Drug Injection in Lumbar Spine Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03513445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*